心血管・腎臓・代謝症候群: 新しい境界線か シンプルなブランド変更か?
Jennifer Manne-Goehler1,2, Willem Daniel Francois Venter3, Mohammed K Ali4,5
1Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
PLoS medicine
|August 21, 2025
まとめ
心血管・腎臓・代謝症候群 (CKM) フレームワークは,複数の心臓,腎臓,代謝疾患を有する患者を支援します. CKM症候群が本当に新しいアプローチなのか,それとも既存の臨床実践の再ブランド化なのかを判断するには,さらなる研究が必要である.
科学分野:
- 心臓病科
- 腎臓科
- 代謝医学
背景:
- 心臓代謝多発症は複雑な臨床的課題を提示する.
- 既存のマネジメントパラダイムは,相互に繋がっているCKM条件を完全に扱えないかもしれません.
- アメリカ心臓協会は,心血管腎臓代謝症候群 (CKM) の枠組みを提案した.
研究 の 目的:
- CKM症候群の枠組みの新しさと臨床的有用性を評価する.
- CKM症候群のアプローチと既存の管理戦略を比較する.
- CKM症候群が 確立された原則の 重要な進歩か ブランド変更かを決定する
主な方法:
- 心臓代謝多病性に関する現在の文献のレビュー
- CKM症候群の枠組みの基本的な原則と提案されたアプリケーションの分析.
- 確立された臨床ガイドラインに対するCKM症候群の比較評価
主要な成果:
- CKM症候群の枠組みは,心血管,腎臓,代謝疾患の管理を統合しています.
- CKMの枠組みは,患者のケアと結果の改善の可能性を示唆しています.
- CKM症候群がどの程度 パラダイムシフトをもたらすかについては,さらなる調査が必要です.
結論:
- CKM症候群の枠組みは,複雑な心代謝状態の管理に構造的なアプローチを提供します.
- 長期的な影響と以前のアプローチからの差異は,継続的な臨床評価を正当化します.
- CKM症候群のユニークな貢献を明らかにすることは,その採用と効果的な実施に不可欠です.
関連する概念動画
Chronic Kidney Disease I: Introduction
67
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
67
Chronic Kidney Disease II: Clinical Manifestations
87
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
87
Chronic Kidney Disease III: Interprofessional Care
78
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
78
Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
Chronic Kidney Disease IV: Nursing Management
55
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
55
Coronary Artery Disease I: Introduction
55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55


